GERON CORP Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
GERON CORP (GERN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 14.48 million shares for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2018-03-16
- GERON CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2017-09-30 was 14.90M shares, a 29.14% increase year-over-year.
- GERON CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2017-06-30 was 14.83M shares, a 26.34% increase year-over-year.
- GERON CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2017-03-31 was 14.78M shares, a 39.17% increase year-over-year.
- GERON CORP antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2016-09-30 was 11.54M shares, a 18.19% increase year-over-year.
- GERON CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2017 was 14.48M shares, a 27.51% increase from fiscal 2016.
- GERON CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2016 was 11.35M shares, a 21.09% increase from fiscal 2015.
- GERON CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2015 was 9.38M shares, a 2.88% increase from fiscal 2014.
- GERON CORP antidilutive securities excluded from computation of earnings per share, amount for fiscal 2014 was 9.11M shares, a 48.16% decline from fiscal 2013.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | 14.48M shares 10-K · filed 2018-03-16 | |||||||
| 2017-09-30 | 14.90M shares 10-Q · filed 2017-11-01 | 14.35M shares 10-Q · filed 2017-11-01 | ||||||
| 2017-06-30 | 14.83M shares 10-Q · filed 2017-08-09 | 14.08M shares 10-Q · filed 2017-08-09 | ||||||
| 2017-03-31 | 14.78M shares 10-Q · filed 2017-05-09 | |||||||
| 2016-12-31 | 11.35M shares 10-K · filed 2018-03-16 | |||||||
| 2016-09-30 | 11.54M shares 10-Q · filed 2017-11-01 | 11.30M shares 10-Q · filed 2017-11-01 | ||||||
| 2016-06-30 | 11.74M shares 10-Q · filed 2017-08-09 | 11.18M shares 10-Q · filed 2017-08-09 | ||||||
| 2016-03-31 | 10.62M shares 10-Q · filed 2017-05-09 | |||||||
| 2015-12-31 | 9.38M shares 10-K · filed 2018-03-16 | |||||||
| 2015-09-30 | 9.76M shares 10-Q · filed 2016-11-03 | 9.50M shares 10-Q · filed 2016-11-03 | ||||||
| 2015-06-30 | 9.83M shares 10-Q · filed 2016-08-03 | 4.88M shares 10-Q · filed 2015-08-05 | 9.34M shares 10-Q · filed 2016-08-03 | 4.54M shares 10-Q · filed 2015-08-05 | ||||
| 2015-03-31 | 8.78M shares 10-Q · filed 2016-05-05 | 4.12M shares 10-Q · filed 2015-05-07 | ||||||
| 2014-12-31 | 9.11M shares 10-K · filed 2017-03-01 | 3.07M shares 10-K · filed 2015-03-11 | ||||||
| 2014-09-30 | 9.90M shares 10-Q · filed 2015-11-05 | 1.93M shares 10-Q · filed 2014-11-05 | 9.37M shares 10-Q · filed 2015-11-05 | 3.21M shares 10-Q · filed 2014-11-05 | ||||
| 2014-06-30 | 787.00K shares 10-Q · filed 2015-08-05 | 3.72M shares 10-Q · filed 2015-08-05 | ||||||
| 2014-03-31 | 5.60M shares 10-Q · filed 2015-05-07 | |||||||
| 2013-12-31 | 17.58M shares 10-K · filed 2016-03-10 | 532.12K shares 10-K · filed 2014-03-17 | ||||||
| 2013-09-30 | 138.34K shares 10-Q · filed 2014-11-05 | 7.18K shares 10-Q · filed 2014-11-05 | ||||||
| 2013-06-30 | 8.31K shares 10-Q · filed 2014-08-11 | 6.53K shares 10-Q · filed 2014-08-11 | ||||||
| 2013-03-31 | 13.95K shares 10-Q · filed 2014-05-01 | |||||||
| 2012-12-31 | 11.50K shares 10-K · filed 2015-03-11 | |||||||
| 2012-09-30 | 16.06K shares 10-Q · filed 2013-11-07 | |||||||
| 2012-06-30 | 23.39K shares 10-Q · filed 2013-08-08 | |||||||
| 2012-03-31 | 58.02K shares 10-Q · filed 2013-05-03 | |||||||
| 2011-12-31 | 294.43K shares 10-K · filed 2014-03-17 | |||||||
| 2011-09-30 | 531.45K shares 10-Q · filed 2012-11-02 | |||||||
| 2011-06-30 | 995.04K shares 10-Q · filed 2012-08-03 | |||||||
| 2010-12-31 | 1.20M shares 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |